Does ESTRAMUSTINE Cause Second primary malignancy? 7 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Second primary malignancy have been filed in association with ESTRAMUSTINE. This represents 2.6% of all adverse event reports for ESTRAMUSTINE.
7
Reports of Second primary malignancy with ESTRAMUSTINE
2.6%
of all ESTRAMUSTINE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From ESTRAMUSTINE?
Of the 7 reports, 1 (14.3%) resulted in death.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESTRAMUSTINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ESTRAMUSTINE Cause?
Nausea (17)
Interstitial lung disease (16)
Cardiac failure (15)
Death (14)
Prostatic specific antigen increased (14)
Pleural effusion (10)
Disease progression (9)
Product use issue (9)
Anaemia (8)
Angioedema (8)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which ESTRAMUSTINE Alternatives Have Lower Second primary malignancy Risk?
ESTRAMUSTINE vs ESTRING
ESTRAMUSTINE vs ESTRIOL
ESTRAMUSTINE vs ESTROGENS
ESTRAMUSTINE vs ESTROGENS, CONJUGATED
ESTRAMUSTINE vs ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE